07.21.2020 - By American College of Physicians
Dr. Centor discusses inflammation-associated anemia and its response to interluekin-1ß inhibition with canakinumab in CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) with trial investigator Dr. Mounica Vallurupalli.